Cargando…
A Single H1 Promoter Can Drive Both Guide RNA and Endonuclease Expression in the CRISPR-Cas9 System
The RNA-guided endonuclease Cas9 (CRISPR-Cas9) genome editing system has been widely used for biomedical research and holds great potential for therapeutic applications in eukaryotes. The conventional vector-based CRISPR-Cas9 delivery system requires two different RNA polymerase promoters for expres...
Autores principales: | Gao, Zongliang, Herrera-Carrillo, Elena, Berkhout, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288460/ https://www.ncbi.nlm.nih.gov/pubmed/30530211 http://dx.doi.org/10.1016/j.omtn.2018.10.016 |
Ejemplares similares
-
Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA
por: Gao, Zongliang, et al.
Publicado: (2020) -
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
por: Sternberg, Samuel H., et al.
Publicado: (2014) -
Improvement of the CRISPR-Cpf1 system with ribozyme-processed crRNA
por: Gao, Zongliang, et al.
Publicado: (2018) -
A CRISPR-Cas Cure for HIV/AIDS
por: Hussein, Mouraya, et al.
Publicado: (2023) -
A combinatorial CRISPR-Cas12a attack on HIV DNA
por: Fan, Minghui, et al.
Publicado: (2022)